BECN1 and chronic myelogenous leukemia, BCR-ABL1 positive: An investigation has assessed if a treatment joining the oncolytic action of an adenoviral vector with the concomitant presence of the gene Beclin-1 presented an improvement for chronic myeloid leukaemia (CML) cells resistant to chemotherapy.